Genetic engineering in the press by GEG
412 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Stéphanie Philippe
Scoop.it!

French biotech Cellectis surges as Pfizer signs cancer drug deal

French biotech Cellectis surges as Pfizer signs cancer drug deal | Genetic engineering in the press by GEG | Scoop.it
(Reuters) - U.S. drugmaker Pfizer, which failed last month in a $118 billion bid to buy AstraZeneca, said on Wednesday it had signed a deal with French biotech Cellectis to develop immunotherapy drugs
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Why gene therapy just got easier

Why gene therapy just got easier | Genetic engineering in the press by GEG | Scoop.it
SOME diseases, such as haemophilia and cystic fibrosis, are caused by broken genes. Doctors have long dreamed of treating them by adding working copies of these...
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Companies Quietly Apply Biofuel Tools to Household Products

Companies Quietly Apply Biofuel Tools to Household Products | Genetic engineering in the press by GEG | Scoop.it
Companies are beginning to use synthetic biology in producing cosmetics and household cleansers, but there is reluctance in how much to publicize it.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Venter to sequence longevity : Nature Biotechnology : Nature Publishing Group

Venter to sequence longevity : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Amgen and Regeneron push for a genetic renaissance in drug discovery : Nature Biotechnology : Nature Publishing Group

Amgen and Regeneron push for a genetic renaissance in drug discovery : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Big oil turns on biofuels : Nature Biotechnology : Nature Publishing Group

Despite government incentives and mandates, second-generation biofuels are proving tough to bring to market. Cormac Sheridan investigates.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Economic and environmental impacts of microbial biodiesel : Nature Biotechnology : Nature Publishing Group

Economic and environmental impacts of microbial biodiesel : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Access : Fabrication of novel biomaterials through molecular self-assembly : Nature Biotechnology

more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

US funds vaccine centers for biodefense : Nature Biotechnology : Nature Publishing Group

US funds vaccine centers for biodefense : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Gene technology regains some of Its luster

Gene technology regains some of Its luster | Genetic engineering in the press by GEG | Scoop.it
Alnylam Pharmaceuticals and a small group of other drug firms are rekindling interest in once-hot gene technology abandoned by big drug makers. The technology seeks to disable molecules called ribonucleic acids, or RNA, from translating genetic code into disease-causing proteins.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Thermo Fisher First-Quarter Profit Rises 62%

Thermo Fisher First-Quarter Profit Rises 62% | Genetic engineering in the press by GEG | Scoop.it
Thermo Fisher Scientific posted a 62% jump in first-quarter profit as the laboratory-equipment maker's results benefited from a recent acquisition, and broad growth in other business segments.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency

Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency | Genetic engineering in the press by GEG | Scoop.it

Pigs have many features that make them attractive as biomedical models, especially in regenerative medicine. Here, we have introduced inactivating mutations simultaneously into both alleles of the recombination activating gene (RAG) 2 gene in fibroblasts derived from minipigs and then used somatic-cell nuclear transfer to produce RAG2−/− cloned animals with a severe immune deficiency (SCID) phenotype and lacking T and B cells. When human induced pluripotent (iPS) cells were injected into these SCID pigs, the animals readily form teratomas representing a wide range of human tissues. Provided they can be protected from pathogens, these genetically engineered pigs could be a valuable resource as models for human patients with analogous immunodeficiencies and for testing the safety and regenerative capacity of grafts derived from iPS cells.

more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Development and Applications of CRISPR-Cas9 for Genome Engineering: Cell

Development and Applications of CRISPR-Cas9 for Genome Engineering: Cell | Genetic engineering in the press by GEG | Scoop.it

"Cas9-mediated genetic perturbation is simple and scalable, empowering researchers to elucidate the functional organization of the genome at the systems level and establish causal linkages between genetic variations and biological phenotypes."

Stéphanie Philippe's insight:

This interesting review published in Cell presents an interesting update on the CRISPR-Cas9 system, an emerging technology that is, thanks to its simplicity, paving the way to the translation of genetic engineering into new opportunities in a wide range of industrial fields, including agrofood, materials and healhcare.

more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Ingenious

Ingenious | Genetic engineering in the press by GEG | Scoop.it
IT SOUNDS like science fiction, and for years it seemed as though it was just that: fiction. But the idea of gene therapy—introducing copies of healthy genes into...
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

GMO corn from Du Pont & Dow gets green light in Europe

GMO corn from Du Pont & Dow gets green light in Europe | Genetic engineering in the press by GEG | Scoop.it
Despite 19 of the EU’s 28 members voting against, American chemicals giants Du Pont and Dow look set to get the seal of approval on growing a strain of genetically modified corn in…
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Putting cells to sleep for future science : Nature Biotechnology : Nature Publishing Group

Putting cells to sleep for future science : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Markets, venture investors and big pharma interest in RNAi soars : Nature Biotechnology : Nature Publishing Group

Markets, venture investors and big pharma interest in RNAi soars : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Relative potential of biosynthetic pathways for biofuels and bio-based products : Nature Biotechnology : Nature Publishing Group

Relative potential of biosynthetic pathways for biofuels and bio-based products : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science : Nature Biotechnology : Nature Publishing Group

Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
The engineering of biomimetic materials is accelerated by combining high-throughput RNA sequencing and proteomics.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Venter to sequence longevity : Nature Biotechnology : Nature Publishing Group

Venter to sequence longevity : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Spreading biotech dollars around Washington : Nature Biotechnology : Nature Publishing Group

Spreading biotech dollars around Washington : Nature Biotechnology : Nature Publishing Group | Genetic engineering in the press by GEG | Scoop.it
The drug industry leads the US in lobbying spending. What does all that money get them? Melanie Senior investigates.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

Artificial DNA breakthrough could lead to new treatments.

Artificial DNA breakthrough could lead to new treatments. | Genetic engineering in the press by GEG | Scoop.it
Researchers for the first time have created microbes containing artificial DNA, expanding the universal genetic code that guides life. The advance one day could lead to new antibiotics, vaccines and other medical products.
more...
No comment yet.
Scooped by Stéphanie Philippe
Scoop.it!

China Seeks Its Own GMO-Food Path - China Real Time Report - WSJ

China Seeks Its Own GMO-Food Path - China Real Time Report - WSJ | Genetic engineering in the press by GEG | Scoop.it
China tries to feed a fifth of the world's population on a seventh of its available land—and not the world’s most fertile, Beijing often complains. So not speed up use of genetically modified food?
more...
No comment yet.